Status: Recruiting
Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity
This multicenter, randomized, double-blind, sham-controlled study is designed to evaluate the efficacy and safety of the iovera° system in subjects with upper extremity spasticity. A total of approximately 132 subjects will be enrolled; 88 subjects will receive treatment with the iovera° system and 44 subjects will receive sham treatment (sham iovera° system treatment).
Participants needed: 132
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Pacira Pharmaceuticals, IncUpdated: Apr 9, 2026Locations: 18
Eligibility criteria
Male or female, 18 years and above. [+7]
History of stroke, traumatic brain injury, and/or spinal cord injury in less tha... [+15]